New guidelines set for occupational HIV exposure.
Rowe
P M
PM
D000062:Accidents, Occupational; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006678:HIV; D015658:HIV Infections / Q000517:prevention & control*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D019469:Indinavir; D017758:Infectious Disease Transmission, Patient-to-Professional; D019259:Lamivudine; D017410:Practice Guidelines as Topic; D011725:Pyridines / Q000008:administration & dosage*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D016047:Zalcitabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D015215:Zidovudine / Q000008:administration & dosage*
D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir; D016047:Zalcitabine